Functionally Improved Mesenchymal Stem Cells to Better Treat Myocardial Infarction
Myocardial infarction (MI) is one of the leading causes of death worldwide. Mesenchymal stem cell (MSC) transplantation is considered a promising approach and has made significant progress in preclinical studies and clinical trials for treating MI. However, hurdles including poor survival, retention...
Saved in:
Main Authors: | Zhi Chen (Author), Long Chen (Author), Chunyu Zeng (Author), Wei Eric Wang (Author) |
---|---|
Format: | Book |
Published: |
Hindawi Limited,
2018-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
How to Improve the Survival of Transplanted Mesenchymal Stem Cell in Ischemic Heart?
by: Liangpeng Li, et al.
Published: (2016) -
Drug-based mobilisation of mesenchymal stem/stromal cells improves cardiac function post myocardial infarction
by: Veneta B. Todorova, et al.
Published: (2023) -
Apelin-13 Pretreatment Promotes the Cardioprotective Effect of Mesenchymal Stem Cells against Myocardial Infarction by Improving Their Survival
by: Guona Chen, et al.
Published: (2022) -
The Application Potential and Advance of Mesenchymal Stem Cell-Derived Exosomes in Myocardial Infarction
by: Xianyun Wang, et al.
Published: (2021) -
MicroRNA-132, Delivered by Mesenchymal Stem Cell-Derived Exosomes, Promote Angiogenesis in Myocardial Infarction
by: Teng Ma, et al.
Published: (2018)